The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Links

 

Gene Review

RFXANK  -  regulatory factor X-associated ankyrin...

Homo sapiens

Synonyms: ANKRA1, Ankyrin repeat family A protein 1, BLS, DNA-binding protein RFXANK, F14150_1, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of RFXANK

  • By pinpointing the interacting residues of the ankyrin repeats of RFXANK, the mechanism of this subtype of severe combined immunodeficiency was revealed [1].
  • RFX-B protein expression in human colorectal adenocarcinomas and in normal adjacent tissue was analysed in this study [2].
  • The level of CPR-training of the GPs was fairly good: 67% had received BLS training on a manikin and 63% had already attended a cardiac arrest event [3].
  • Respondents with significantly higher (more negative reactions) AIDSTRESS scores were: BLS providers, men, paid providers, personnel with more than 3 years of field experience, those working in urban areas, personnel with no formal education beyond high school, and those who stated that their HIV/AIDS training was inadequate [4].
  • RESULTS: All persons of the 'only BLS-trained' group delivered the three sequential ('stacked') shocks with the automatic external defibrillator when persistent ventricular fibrillation was simulated [5].
 

Psychiatry related information on RFXANK

  • The effect of basic and advanced cardiac life support (BLS and ACLS) on long-term survival is dependent upon both the response time and the quality of intervention [6].
  • When EMS providers at both the BLS and ALS levels leave their training programs, they are armed with newfound knowledge, but they usually lack the appropriate life experiences to excel and survive on the streets [7].
 

High impact information on RFXANK

  • RFXANK restores MHC-II expression in cell lines from patients in group B and is mutated in these patients [8].
  • RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency [9].
  • This finding provided the basis for a high-resolution structure-function analysis of the ARD of RFXANK, which allowed us to map the RFX5 interaction domain and residues critical for assembly of the RFX complex [10].
  • We discovered that ANKRA2, the closest paralogue of RFXANK, can substitute for RFXANK in the activation of MHC-II genes and that this ability is mediated by its ankyrin repeat domain (ARD) [10].
  • We also found that mutations in the fourth ankyrin repeat of RFXANK abolish assembly of the enhanceosome on MHC-II promoters in vivo but not in vitro, suggesting a new role of RFXANK in facilitating promoter occupation in the context of chromatin [10].
 

Chemical compound and disease context of RFXANK

 

Biological context of RFXANK

  • New functions of the major histocompatibility complex class II-specific transcription factor RFXANK revealed by a high-resolution mutagenesis study [10].
  • We investigated the in vivo effects of these mutations and of three other point mutations on the expression of the RFXANK RNA and protein [13].
  • A founder effect for this mutation was documented, since all tested patients, except one, display a common haplotype spanning the RFXANK locus [14].
  • Additionally, we show that interferon-gamma, which induces Class II MHC gene expression in 293 cells, promotes a shift in the splicing pattern of RFXANK/Tvl-1 toward the transcriptionally active Tvl-L isoform, suggesting that differential splicing of Tvl-1 is a signal-regulated process [15].
  • Altogether, we characterize a new type of mutation in the RFXANK gene in a MHC class II-defective patient leading to an uncoordinated expression of the HLA-D genes, and propose that this phenotype is ensured by severely limited amounts of an active, although truncated RFXANK protein [16].
 

Anatomical context of RFXANK

 

Associations of RFXANK with chemical compounds

  • This indicates that an aromatic ring, but not the phenyl chain of tyrosine, is necessary at position 224 for normal RFXANK function [13].
 

Physical interactions of RFXANK

 

Other interactions of RFXANK

  • The RFXANK gene encodes one subunit of the heterotrimeric RFX complex that is involved in the assembly of several transcription factors on MHC II promoters [13].
  • These genes encode RFXANK, RFXS, RFXAP and CIITA [22].
  • Unlike RFX5- and RFXAP-deficient cells, transfection of exogenous class II transactivator (CIITA) into these RFX-B-deficient fibroblasts resulted in the induction of HLA-DR and HLA-DP and, to a lesser extent, HLA-DQ [19].
  • Uncoordinated HLA-D gene expression in a RFXANK-defective patient with MHC class II deficiency [16].
 

Analytical, diagnostic and therapeutic context of RFXANK

References

  1. Analysis of ankyrin repeats reveals how a single point mutation in RFXANK results in bare lymphocyte syndrome. Nekrep, N., Geyer, M., Jabrane-Ferrat, N., Peterlin, B.M. Mol. Cell. Biol. (2001) [Pubmed]
  2. RFX-B, a MHC class II transcription factor, suppressed in human colorectal adenocarcinomas. Dimberg, J., Hugander, A., Häll-Karlsson, B.M., Sirsjö, A. Int. J. Mol. Med. (2002) [Pubmed]
  3. Knowledge, skills and counselling behaviour of Belgian general practitioners on CPR-related issues. Bossaert, L.L., Putzeys, T., Monsieurs, K.G., Van Hoeyweghen, R.J. Resuscitation. (1992) [Pubmed]
  4. Treatment and career attitudes of prehospital care providers associated with potential exposure to HIV/AIDS. Eastham, J.N., Thompson, M.E., Ryan, P.A. The American journal of emergency medicine. (1991) [Pubmed]
  5. Successful automatic external defibrillator operation by people trained only in basic life support in a simulated cardiac arrest situation. Domanovits, H., Meron, G., Sterz, F., Kofler, J., Oschatz, E., Holzer, M., Müllner, M., Laggner, A.N. Resuscitation. (1998) [Pubmed]
  6. Can better basic and advanced cardiac life support improve outcome from cardiac arrest? Kaye, W., Mancini, M.E., Rallis, S.F., Linhares, K.C., Angell, M.L., Donovan, D.S., Zajano, N.C., Finger, J.A. Crit. Care Med. (1985) [Pubmed]
  7. Staying on top--9 rules for surviving and excelling on the streets. Tkach, T., Rumpf, J. JEMS : a journal of emergency medical services. (1995) [Pubmed]
  8. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients. Masternak, K., Barras, E., Zufferey, M., Conrad, B., Corthals, G., Aebersold, R., Sanchez, J.C., Hochstrasser, D.F., Mach, B., Reith, W. Nat. Genet. (1998) [Pubmed]
  9. RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency. Nagarajan, U.M., Louis-Plence, P., DeSandro, A., Nilsen, R., Bushey, A., Boss, J.M. Immunity (1999) [Pubmed]
  10. New functions of the major histocompatibility complex class II-specific transcription factor RFXANK revealed by a high-resolution mutagenesis study. Krawczyk, M., Masternak, K., Zufferey, M., Barras, E., Reith, W. Mol. Cell. Biol. (2005) [Pubmed]
  11. An evaluation of the effectiveness of the Opportunities for Resuscitation and Citizen Safety (ORCS) defibrillator training programme designed for older school children. Younas, S., Raynes, A., Morton, S., Mackway-Jones, K. Resuscitation. (2006) [Pubmed]
  12. Luminescence studies of the phagocyte response to endotoxin infusion into normal human subjects: multiple discriminant analysis of luminescence response and correlation with phagocyte morphologic changes and release of elastase. Taylor, F., Haddad, P.A., Kinasewitz, G., Chang, A., Peer, G., Allen, R.C. J. Endotoxin Res. (2000) [Pubmed]
  13. Novel mutations in the RFXANK gene: RFX complex containing in-vitro-generated RFXANK mutant binds the promoter without transactivating MHC II. Wiszniewski, W., Fondaneche, M.C., Louise-Plence, P., Prochnicka-Chalufour, A., Selz, F., Picard, C., Le Deist, F., Eliaou, J.F., Fischer, A., Lisowska-Grospierre, B. Immunogenetics (2003) [Pubmed]
  14. Founder effect for a 26-bp deletion in the RFXANK gene in North African major histocompatibility complex class II-deficient patients belonging to complementation group B. Wiszniewski, W., Fondaneche, M.C., Lambert, N., Masternak, K., Picard, C., Notarangelo, L., Schwartz, K., Bal, J., Reith, W., Alcaide, C., de Saint Basile, G., Fischer, A., Lisowska-Grospierre, B. Immunogenetics (2000) [Pubmed]
  15. Differential splicing generates Tvl-1/RFXANK isoforms with different functions. Das, S., Lin, J.H., Papamatheakis, J., Sykulev, Y., Tsichlis, P.N. J. Biol. Chem. (2002) [Pubmed]
  16. Uncoordinated HLA-D gene expression in a RFXANK-defective patient with MHC class II deficiency. Lennon-Duménil, A.M., Barbouche, M.R., Vedrenne, J., Prod'Homme, T., Béjaoui, M., Ghariani, S., Charron, D., Fellous, M., Dellagi, K., Alcaïde-Loridan, C. J. Immunol. (2001) [Pubmed]
  17. Direct genetic correction as a new method for diagnosis and molecular characterization of MHC class II deficiency. Matheux, F., Ikinciogullari, A., Zapata, D.A., Barras, E., Zufferey, M., Dogu, F., Regueiro, J.R., Reith, W., Villard, J. Mol. Ther. (2002) [Pubmed]
  18. Assignment of ankyrin repeat, family A (RFXANK-like) 2 (ANKRA2) to human chromosome 5q12-->q13 by radiation hybrid mapping and somatic cell hybrid PCR. Rader, K., Boyer, A.D., Farquhar, M.G., Arden, K.C. Cytogenet. Cell Genet. (2000) [Pubmed]
  19. Novel mutations within the RFX-B gene and partial rescue of MHC and related genes through exogenous class II transactivator in RFX-B-deficient cells. Nagarajan, U.M., Peijnenburg, A., Gobin, S.J., Boss, J.M., van den elsen, P.J. J. Immunol. (2000) [Pubmed]
  20. Characterization of ANKRA, a novel ankyrin repeat protein that interacts with the cytoplasmic domain of megalin. Rader, K., Orlando, R.A., Lou, X., Farquhar, M.G. J. Am. Soc. Nephrol. (2000) [Pubmed]
  21. Major histocompatibility complex class II transcriptional platform: assembly of nuclear factor Y and regulatory factor X (RFX) on DNA requires RFX5 dimers. Jabrane-Ferrat, N., Nekrep, N., Tosi, G., Esserman, L.J., Peterlin, B.M. Mol. Cell. Biol. (2002) [Pubmed]
  22. Lessons from the bare lymphocyte syndrome: molecular mechanisms regulating MHC class II expression. Waldburger, J.M., Masternak, K., Muhlethaler-Mottet, A., Villard, J., Peretti, M., Landmann, S., Reith, W. Immunol. Rev. (2000) [Pubmed]
  23. Expansion of emergency medicine's responsibilities for preclinical education of medical students. Burdick, W.P., Davidson, S.J. Annals of emergency medicine. (1985) [Pubmed]
  24. Quality of BLS decreases with increasing resuscitation complexity. Rittenberger, J.C., Guimond, G., Platt, T.E., Hostler, D. Resuscitation. (2006) [Pubmed]
 
WikiGenes - Universities